Liminatus Pharma Inc's Customers Performance

Name: Liminatus Pharma Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

LIMN

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


LIMN's Source of Revenues		• List of LIMN Customers

for the same period Liminatus Pharma Inc

• List of LIMN Customers

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Liminatus Pharma Inc's Comment on Sales, Marketing and Customers

The company engaged in licensing and development agreements concerning YN1203, InnoBation Bio CAR NK biomarkers, and CD47 Products. Metavagen was assigned the License and Development Agreement with InnoBation Bio Co. Ltd. and Valetudo Therapeutics LLC, granting it exclusive worldwide rights to develop and commercialize the CD47 Product and companion diagnostics. Viral Gene paid $8.2 million upfront to InnoBation Bio for development costs. The license agreement includes provisions for royalty payments and management fees and may be terminated under conditions such as breach or insolvency. The company also addresses U.S. patent term restoration and marketing exclusivity under the Hatch-Waxman Amendments related to FDA approval processes for biological products. Customers and markets mentioned include InnoBation Bio Co. Ltd., Metavagen, Valetudo Therapeutics LLC, and Viral Gene.

Liminatus Pharma Inc’s Comment on Sales, Marketing and Customers

LIMN's Stock Performance relative to it's Customers

LIMN's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Liminatus Pharma Inc	4.06	0.00	-12.85	1
SUBTOTAL	0.00	0.00	0.00	-

Sources: Liminatus Pharma Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Liminatus Pharma Inc’s corporate clients.
For your research, we’ve provided 9 tables on Liminatus Pharma Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.